Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1934616
Max Phase: Preclinical
Molecular Formula: C60H86N2O27S3
Molecular Weight: 1363.54
Molecule Type: Small molecule
Associated Items:
ID: ALA1934616
Max Phase: Preclinical
Molecular Formula: C60H86N2O27S3
Molecular Weight: 1363.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)c1cccc2c(S(=O)(=O)NCCSCCCCCS[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O[C@H]7O[C@H](COCc8ccc9ccccc9c8)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)cccc12
Standard InChI: InChI=1S/C60H86N2O27S3/c1-62(2)34-14-8-13-33-32(34)12-9-15-40(33)92(78,79)61-18-21-90-19-6-3-7-20-91-60-51(77)46(72)55(38(26-66)85-60)89-59-50(76)45(71)54(37(25-65)83-59)88-58-49(75)44(70)53(36(24-64)82-58)87-57-48(74)43(69)52(35(23-63)81-57)86-56-47(73)42(68)41(67)39(84-56)28-80-27-29-16-17-30-10-4-5-11-31(30)22-29/h4-5,8-17,22,35-39,41-61,63-77H,3,6-7,18-21,23-28H2,1-2H3/t35-,36-,37-,38-,39-,41-,42+,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60+/m1/s1
Standard InChI Key: XMTBFFZSKDELTB-XKNUBBOWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1363.54 | Molecular Weight (Monoisotopic): 1362.4580 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Oka H, Koyama T, Hatano K, Matsuoka K.. (2012) Synthetic studies of bi-fluorescence-labeled maltooligosaccharides as substrates for α-amylase on the basis of fluorescence resonance energy transfer (FRET)., 20 (1): [PMID:22100259] [10.1016/j.bmc.2011.10.065] |
Source(1):